nelipepimut-s

Vaccineexperimental

Clinical trial activity

6 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
6
Phase 3
1
Phase 4
0

Earliest trial started Jul 1, 2001 (NCT00841399)

Timeline

2000s

  1. Jan 1, 2001

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • e75 + gm-csf vaccine
  • nelipepimut-s
  • nelipepimut-s
  • neuvax
  • neuvax

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02636582Phase 2Jun 14, 2016National Cancer Institute (NCI), University of Texas at Houston
NCT02297698Phase 2Oct 1, 2014Cancer Insight, LLC, Galena Biopharma, Inc., Genentech
NCT01570036Phase 2Jan 1, 2013Cancer Insight, LLC, Galena Biopharma, Inc., Genentech
NCT01479244Phase 3Nov 1, 2011Galena Biopharma, Inc., University of Texas at Houston
NCT00854789Phase 1/Phase 2 (Phase 2)Dec 1, 2002San Antonio Military Medical Center, Uniformed Services University of the Health Sciences, United States Army
NCT00841399Phase 1/Phase 2 (Phase 2)Jul 1, 2001San Antonio Military Medical Center, Uniformed Services University of the Health Sciences, United States Army
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Galena Biopharma, Inc.For profit3122011
Cancer Insight, LLCFor profit2212013
GenentechFor profit2012013
San Antonio Military Medical CenterAcademic/Hospital2212001
Uniformed Services University of the Health SciencesGovernment2012001
United States ArmyGovernment2012001
University of Texas at HoustonAcademic/Hospital2022011
National Cancer Institute (NCI)Government1112016
8 organizations
Page 1 / 1